what is calcitonin gene related peptide Related Peptide - 降钙素基因相关肽 neuropeptide widely distributed throughout the human body What is Calcitonin Gene-Related Peptide (CGRP)?

Cgrpr Calcitonin gene-related peptide (CGRP) is a neuropeptide that plays a significant role in various physiological processes throughout the human body. This 37-amino acid peptide is widely distributed in both the central and peripheral nervous systems, as well as in other tissues. Its functions are diverse, but it is perhaps most recognized for its involvement in regulating blood vessel expansion and its prominent association with migraine headaches.Calcitonin gene-related peptidereceptor.Calcitonin gene-related peptide(CGRP) is involved in central and peripheral sensitization during inflammation and ... Understanding CGRP is crucial for comprehending its impact on conditions like migraine and its potential as a therapeutic target.

The Biology and Distribution of CGRP

CGRP is a member of the calcitonin family of peptides and is encoded by the CALCA gene. This gene gives rise to two primary isoforms: alpha-CGRP (α-CGRP) and beta-CGRP (β-CGRP), produced through alternative RNA splicing. CGRP is synthesized in sensory and motor neurons, and its presence extends throughout the body, indicating its broad physiological influence.2023年9月26日—CGRP is a protein that helps control blood vessel expansion. It has functions all over the body but is of particular interest to people ... Its potent vasoactive properties mean it can significantly affect blood flow by causing vasodilation, or the widening of blood vessels.Calcitonin Gene Related Peptide II (CGRP II, human), cyclic This characteristic is central to its role in conditions like migraine, where changes in cranial blood vessels are implicatedCalcitonin Gene-Related Peptide Receptor - StatPearls - NCBI.

CGRP's Role in Migraine

The connection between CGRP and migraine has been a significant area of research, leading to the development of novel therapeutic strategies. During a migraine attack, CGRP is released from trigeminal nerves, which are involved in facial sensation and pain. This release contributes to the vasodilation of cranial blood vessels, inflammation, and the transmission of pain signals, all of which are hallmarks of migraine. Consequently, targeting CGRP has become a key approach in migraine management.

Therapeutic Applications: CGRP Inhibitors and Antagonists

The understanding of CGRP's role in migraine has paved the way for a new class of medications designed to block its effects. CGRP inhibitors and antagonists work by either preventing CGRP from binding to its receptors or by neutralizing CGRP itself.Calcitonin gene-related peptidereceptor.Calcitonin gene-related peptide(CGRP) is involved in central and peripheral sensitization during inflammation and ... These treatments, including monoclonal antibodies and small molecule antagonists (often referred to as "gepants"), have shown considerable promise as preventive and acute treatments for migraine, offering a targeted approach to managing this often debilitating conditionCalcitonin Gene Related Peptide,CGRP(alpha), human ...Calcitonin gene-related peptide(CGRP) is a 37-amino acid neuropeptide produced by tissue specific processing of the calcitonin gene and is the major product in neural tissues.. Research also continues into the broader systemic effects of CGRP, exploring its potential involvement in cardiovascular diseases and other physiological processesCalcitonin Gene Related Peptide (CGRP) stands for calcitonin gene-related peptide, and it is a protein that is released around the brain..